-+ 0.00%
-+ 0.00%
-+ 0.00%

JASPER THERAPEUTICS - FIRST FSGS PATIENT IN PHASE 2 STUDY EXPECTED TO BE DOSED IN Q1 2027

Reuters·10/15/2026 12:05:24